Catalyze appoints Commercial Director for advancing its ambitions
Amsterdam, November 1st, 2017.
The management of Catalyze is happy to announce the appointment of Quirein te Roller as its Commercial Director. Quirein’s main focus will be on further professionalizing the Sales and Business Development Organization both in The Netherlands and abroad. Furthermore, Quirein will lead the strengthening of our Strategic Funding Unit (SFU) and Marketing & Communications activities.
Quirein holds an MBA from TIAS Business School and a certificate from Harvard Business School Executive Education Program. He has held sales and account management positions of increasing responsibility in a number of commercial organizations. Over the past 6 years, he was Director of Sales and Account Management for ANP Business.
In the past few years, Catalyze has evolved into a market leader in obtaining funding for biomedical and healthcare innovations. The company has built a network of more than 1,000 partners in Europe and beyond, and raised close to half a billion Euro in funding for its clients. Catalyze continues to experience strong growth in terms of its services and number of clients. The company has the ambition to continue its growth in the future and expand its market position in and beyond Europe.
Catalyze founder and director Theodoor Rutgers: “We have seen our company grow rapidly and our ambition is to continue doing so, whilst maintaining our high standards of quality and client focus. With Quirein on board, focusing on the commercial side of our business both here and abroad, Catalyze will be able to service an ever-increasing number of innovative organizations in consulting and executing on the optimal funding strategies and grant applications.” Quirein te Roller: “I am very excited to be joining Catalyze. The company has a very strong base in the field of life sciences and I am looking forward to help Catalyze achieve its goals in becoming the market leader in Europe and beyond.”
Catalyze is a market leader in obtaining funding for biomedical and healthcare innovations, as well as for projects in the related ICT, eHealth and big data fields. Catalyze helps leading researchers and companies secure financing for ambitious R&D projects, from early stage pre-clinical research up to clinical stage development. Catalyze combines subsidies, loans and venture capital, tailored to the client’s plans and ambitions. Catalyze supports a variety of Life Sciences developments including, but not limited to, diagnostics, pharmaceuticals, medical devices and healthcare solutions. The company has a strong passion for the latest technological innovations and its top consultants work with the best clients and projects in Europe and beyond. Catalyze has the ambition to further expand internationally and into other sectors than Life Sciences, in which it is steadily increasing its track record as well.